Research.Patient.info

Resectable Gastric Cancer research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingTherapeutic exploratory (Phase II)
Perioperative Treatment in Resectable Gastric Cancer with Spartalizumab (PDR001) in Combination with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT): A phase II study (GASPAR)
This study is testing a new combination of treatments for stomach cancer that can be removed with surgery. It combines a new drug, spartalizumab, with a standard chemotherapy (FLOT). Researchers want to see if this new combination helps shrink the cancer more before surgery and improves outcomes.
France